share_log

Investors in Acadia Healthcare Company (NASDAQ:ACHC) Have Seen Splendid Returns of 209% Over the Past Five Years

Investors in Acadia Healthcare Company (NASDAQ:ACHC) Have Seen Splendid Returns of 209% Over the Past Five Years

在过去五年中,阿卡迪亚医疗保健公司(纳斯达克股票代码:ACHC)的投资者获得了209%的丰厚回报
Simply Wall St ·  01/19 05:41

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But on the bright side, you can make far more than 100% on a really good stock. For example, the Acadia Healthcare Company, Inc. (NASDAQ:ACHC) share price has soared 209% in the last half decade. Most would be very happy with that. On top of that, the share price is up 13% in about a quarter. But this could be related to the strong market, which is up 13% in the last three months.

在购买公司股票(假设没有杠杆作用)之后,最糟糕的结果是你损失了所有投入的资金。但好的一面是,购买一只非常好的股票,您可以赚取超过100%的收入。例如,阿卡迪亚医疗保健公司(纳斯达克股票代码:ACHC)的股价在过去五年中飙升了209%。大多数人会对此感到非常满意。最重要的是,股价在大约一个季度内上涨了13%。但这可能与强劲的市场有关,市场在过去三个月中上涨了13%。

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

考虑到这一点,值得一看公司的基本面是否是长期业绩的驱动力,或者是否存在一些差异。

See our latest analysis for Acadia Healthcare Company

查看我们对阿卡迪亚医疗公司的最新分析

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

尽管一些人继续教导高效市场假说,但事实证明,市场是反应过度的动态系统,投资者并不总是理性的。通过比较每股收益(EPS)和股价随时间推移的变化,我们可以了解投资者对公司的态度随着时间的推移而发生了怎样的变化。

Over half a decade, Acadia Healthcare Company managed to grow its earnings per share at 38% a year. We do note that extraordinary items have impacted its earnings history. This EPS growth is higher than the 25% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock.

在过去的五年中,阿卡迪亚医疗公司设法将其每股收益增长到每年38%。我们确实注意到,非同寻常的项目影响了其收益记录。每股收益的增长高于股价25%的平均年增长率。因此,人们可以得出结论,整个市场对该股变得更加谨慎。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何随着时间的推移而发生的变化(点击图片发现确切的数值)。

earnings-per-share-growth
NasdaqGS:ACHC Earnings Per Share Growth January 19th 2024
纳斯达克GS:ACHC每股收益增长 2024年1月19日

It might be well worthwhile taking a look at our free report on Acadia Healthcare Company's earnings, revenue and cash flow.

可能值得一看我们关于阿卡迪亚医疗公司收益、收入和现金流的免费报告。

A Different Perspective

不同的视角

Acadia Healthcare Company shareholders are up 0.5% for the year. Unfortunately this falls short of the market return. It's probably a good sign that the company has an even better long term track record, having provided shareholders with an annual TSR of 25% over five years. It's quite possible the business continues to execute with prowess, even as the share price gains are slowing. It's always interesting to track share price performance over the longer term. But to understand Acadia Healthcare Company better, we need to consider many other factors. Even so, be aware that Acadia Healthcare Company is showing 2 warning signs in our investment analysis , you should know about...

阿卡迪亚医疗公司的股东今年上涨了0.5%。不幸的是,这没有达到市场回报率。这可能是一个好兆头,表明该公司的长期业绩记录甚至更好,在五年内为股东提供了25%的年度股东总回报率。尽管股价上涨放缓,但该业务很有可能继续表现出色。长期跟踪股价表现总是很有意思的。但是,要更好地了解阿卡迪亚医疗保健公司,我们需要考虑许多其他因素。即便如此,请注意,阿卡迪亚医疗保健公司在我们的投资分析中显示了两个警告信号,你应该知道...

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

当然,通过寻找其他地方,你可能会找到一笔不错的投资。因此,请看一下我们预计收益将增加的这份免费公司名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报率。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,发送电子邮件给编辑组(网址为)simplywallst.com。
Simply Wall St 的这篇文章本质上是笼统的。我们仅使用公正的方法提供基于历史数据和分析师预测的评论,我们的文章并非旨在提供财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不会考虑最新的价格敏感型公司公告或定性材料。华尔街只是没有持有上述任何股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发